Analystreport

Dermira Inc (NASDAQ: DERM) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $18.75 price target on the stock.

Journey Medical Corporation  (DERM) 
Last journey medical corporation earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.dermira.com